Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in Calcified Tissue International
- Vol. 54 (1) , 26-29
- https://doi.org/10.1007/bf00316285
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans.Journal of Clinical Endocrinology & Metabolism, 1993
- Immunoassay for urinary pyridinoline: The new marker of bone resorptionJournal of Bone and Mineral Research, 1993
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992
- Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.Annals of the Rheumatic Diseases, 1992
- Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism.Journal of Clinical Endocrinology & Metabolism, 1992
- Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.Journal of Clinical Endocrinology & Metabolism, 1992
- New biomarkers of bone resorption.Journal of Clinical Endocrinology & Metabolism, 1992
- Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseasesEuropean Journal of Clinical Investigation, 1991
- Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosisJournal of Bone and Mineral Research, 1991
- Exogenous triiodothyronine activates bone remodelingBone, 1987